Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.35
Bid: 27.25
Ask: 27.50
Change: 0.15 (0.55%)
Spread: 0.25 (0.917%)
Open: 27.50
High: 27.50
Low: 27.10
Prev. Close: 27.20
SHI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing and Open Offer and Firm Placing

8 Apr 2009 17:27

RNS Number : 3918Q
SIG PLC
08 April 2009
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA. 

This announcement is not an offer of securities for sale in the United States. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") and may not be offered or sold in the United States absent registration or an exemption from registration under the US Securities Act. No public offering of the securities discussed herein is being made in the United States and the information contained herein does not constitute an offering of securities for sale in the United States, Canada, Australia, Japan or South Africa.

SIG plc

8 April 2009 

Result of Placing and Open Offer and Firm Placing

On 18 March 2009, the Board of Directors of SIG plc ("SIG" or the "Company") announced details of a proposed Placing and Open Offer and Firm Placing to raise approximately £325 million (net of expenses) through the issue of 455,047,973 New Ordinary Shares at an Issue Price of 75 pence per New Ordinary Share, with 213,345,345 New Ordinary Shares to be issued through the Placing and Open Offer and 241,702,628 New Ordinary Shares to be issued through the Firm Placing. 

The Open Offer closed for acceptance at 11a.m. on 8 April 2009. SIG is pleased to announce that it has received valid acceptances under the Open Offer in respect of 191,045,736 Open Offer Shares from Qualifying Shareholders. This represents approximately 89.55 per cent. of the Open Offer Shares offered pursuant to the Open Offer.

Accordingly, the remaining 22,299,609 Open Offer Shares, representing approximately 10.45 per cent. of the Open Offer Shares issued through the Placing and Open Offer, have been allocated to the investors with whom they had been conditionally placed. 

The Placing and Open Offer and Firm Placing is conditional upon, amongst other things, the approval of Shareholders at the Extraordinary General Meeting (scheduled for 9 April 2009) and upon Admission. The 455,047,973 New Ordinary Shares are expected to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities with effect from 8.00 a.m. on Tuesday, 14 April, 2009. Thereafter SIG will have a total of 590,813,193 shares issued and outstanding. 

Set out below is an expected timetable of principal events in relation to the Placing and Open Offer and Firm Placing. 

Event
Time/date
Extraordinary General Meeting
9.30 a.m. on 9 April 2009
Admission and commencement of dealings in the New Ordinary Shares
8.00 a.m. on 14 April 2009
New Ordinary Shares in uncertificated form expected to be credited to accounts in CREST
8.00 a.m. on 14 April 2009
Despatch of definitive share certificates for the New Ordinary Shares in certificated form
by 20 April 2009

General notes:

1. Reference to times in this announcement are to London time unless otherwise stated.

2. The times and dates set out in the expected timetable of principal events above and mentioned throughout this announcement may be adjusted by SIG, in which event details of the new times and dates will be notified to the UK Listing Authority, the London Stock Exchange and, where appropriate, Qualifying Shareholders. In particular, in the event that withdrawal rights arise under Section 87Q of FSMA prior to Admission, SIG, J.P. Morgan Cazenove, J.P. Morgan Securities and Panmure Gordon may agree to defer Admission until such time as such withdrawal rights no longer apply.

3. Different deadlines and procedures for return of forms may apply in certain cases.

This announcement should be read in conjunction with the full text of the combined circular and prospectus published by SIG and circulated to Shareholders on 18 March 2009 (the "Prospectus"). A copy of the Prospectus is available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at: The Financial Services Authority25 The North Colonnade, Canary Wharf, London E14 5HS. In addition, copies of the Prospectus are available for inspection during normal business hours on Monday to Friday of each week (public holidays excepted) at Company at Signet House, 17 Europa View, Sheffield Business Park, Sheffield S9 1XH. In addition the Prospectus is available for inspection at the offices of Pinsent Masons LLP, CityPoint, One Ropemaker Street, London EC2Y 9AH up to and including the date of Admission and has also been published at www.sigplc.co.uk.

Capitalised terms used, but not defined, in this announcement have the same meanings as given to them in the Prospectus. 

For further information, please contact: 

SIG plc

Chris Davies

Gareth Davies

+44 (0) 11 4285 6300 

J.P. Morgan Cazenove (Joint Sponsor, Joint Financial Adviser and Joint Broker)

Edmund Byers

Steve Baldwin

+44 (0) 20 7588 2828

Panmure Gordon (Joint Sponsor, Joint Financial Adviser and Joint Broker) 

Hugh Morgan

Adam Pollock

+44 (0) 20 7459 3600

Lazard (Joint Financial Adviser) 

Peter Kiernan

Vasco Litchfield

+44 (0) 20 7187 2000

This announcement has been issued by, and is the sole responsibility of, SIG plc (the "Company"). No representation or warranty, express or implied, is made or given by, or on behalf of, the Company, J.P. Morgan Cazenove Limited ("J.P. Morgan Cazenove"), J.P. Morgan Securities Ltd. ("J.P. Morgan Securities") , Lazard & Co., Ltd ("Lazard") or Panmure Gordon (UK) Limited ("Panmure Gordon") or any of their affiliates, parent undertakings, subsidiary undertakings or subsidiaries of their parent undertakings or any of their respective directors, officers, employees or advisers or any other person as to the accuracy or completeness or fairness of the information or opinions contained in this announcement and no responsibility or liability is accepted by any of them for any such information or opinions or for any errors or omissions.

J.P. Morgan Cazenove, J.P. Morgan Securities, Lazard and Panmure Gordon, each of which is authorised and regulated in the UK by the FSA, are acting exclusively for SIG and no one else in connection with the Placing and Open Offer and Firm Placing and will not regard any other person (whether or not a recipient of this announcement) as their respective client in relation to the Placing and Open Offer and Firm Placing and will not be responsible to anyone other than SIG for providing the protections afforded to their respective clients or for providing advice in connection with the Placing and Open Offer and Firm Placing or any other matter referred to in this announcement.

IMPORTANT NOTICE: 

This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any New Ordinary Shares, nor shall it (or any part of it), or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract or commitment whatsoever with respect to the proposed Placing and Open Offer and Firm Placing or otherwise. This announcement is not a prospectus and investors should not subscribe for or purchase any New Ordinary Shares referred to in this announcement except on the basis of information in the Prospectus.

The distribution of this announcement in certain jurisdictions may be restricted by law and such distribution could result in violation of the laws of such jurisdictions. In particular, this announcement is not for distribution in the United States, Australia, Canada, Japan or South Africa.

This announcement is not an offer of securities for sale in the United States. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") and may not be offered or sold in the United States absent registration or an exemption from registration under the US Securities Act. No public offering of the securities discussed herein is being made in the United States and the information contained herein does not constitute an offering of securities for sale in the United States, Canada, Australia, Japan or South Africa. This announcement is not for distribution directly or indirectly in or into the United States, Canada, Australia, Japan or South Africa.

The information in this press release may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction, or disclosure of this information in whole or in part is unauthorized. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions.

Neither the content of SIG's website (or any other website) nor the content of any website accessible from hyperlinks on SIG's website (or any other website) is incorporated into, or forms part of, this announcement.

This announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIBLGDSSDGGGCI
Date   Source Headline
2nd May 20241:53 pmRNSResult of AGM
2nd May 20247:00 amRNSTrading Update
12th Apr 20244:01 pmRNSDirector/PDMR Shareholding
4th Apr 202410:12 amRNSDirector/PDMR Shareholding
25th Mar 202410:21 amRNSNotice of AGM
22nd Mar 202410:30 amRNSDirector/PDMR Shareholding
22nd Mar 202410:12 amRNSDirector/PDMR Shareholding
5th Mar 202412:14 pmRNSAnnual Financial Report
5th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
9th Jan 20247:00 amRNS2023 Full Year Trading Update
1st Dec 20235:42 pmRNSDirector/PDMR Shareholding
23rd Nov 20239:00 amRNSCapital Markets Event
13th Nov 20239:00 amRNSNotice of Capital Markets Event
13th Oct 20233:51 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSQ3 Trading Update
25th Sep 20233:56 pmRNSDirectorate Change
9th Aug 20234:58 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSHalf-year Report
12th Jul 20234:26 pmRNSHolding(s) in Company
11th Jul 20234:06 pmRNSHolding(s) in Company
11th Jul 202310:58 amRNSHolding(s) in Company
10th Jul 202311:09 amRNSHolding(s) in Company
5th Jul 20233:15 pmRNSHolding(s) in Company
5th Jul 20237:00 amRNSH1 Trading Update
4th May 20232:32 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
31st Mar 202312:47 pmRNSHolding(s) in Company
27th Mar 202310:30 amRNSNotice of AGM
13th Mar 20233:49 pmRNSDirector/PDMR Shareholding
13th Mar 20233:39 pmRNSDirector/PDMR Shareholding
13th Mar 202310:36 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSDirector/PDMR Shareholding
8th Mar 20231:20 pmRNSAnnual Financial Report
8th Mar 20237:01 amRNSDirectorate Changes
8th Mar 20237:00 amRNSFull year results for the year ended 31 Dec 2022
27th Feb 202311:20 amRNSDirector Declaration
1st Feb 20237:00 amRNSDirectorate Change
10th Jan 20237:00 amRNS2022 Full Year Trading Update
16th Dec 20228:04 amRNSDirector Declaration
15th Sep 202210:49 amRNSDirectorate Changes
13th Sep 20224:59 pmRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSCEO Steve Francis to be succeeded by Gavin Slark
9th Aug 20227:00 amRNSHalf-year Report
25th Jul 20227:00 amRNSAcquisition of Miers Construction Products Limited
1st Jul 20229:38 amRNSNotice of Half Year Results
22nd Jun 20229:53 amRNSChange of Adviser
12th May 20226:11 pmRNSResult of AGM
12th May 20222:52 pmRNSResult of AGM
29th Apr 20227:00 amRNSTrading Update
12th Apr 20223:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.